Rapid communication Open Access
Like 0


Following emergence of the SARS-CoV-2 variant Omicron in November 2021, the dominant BA.1 sub-lineage was replaced by the BA.2 sub-lineage in Denmark. We analysed the first 2,623 BA.2 cases from 29 November 2021 to 2 January 2022. No epidemiological or clinical differences were found between individuals infected with BA.1 versus BA.2. Phylogenetic analyses showed a geographic east-to-west transmission of BA.2 from the Capital Region with clusters expanding after the Christmas holidays. Mutational analysis shows distinct differences between BA.1 and BA.2.


Article metrics loading...

Loading full text...

Full text loading...



  1. Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022. Epub ahead of print.  https://doi.org/10.1038/s41586-022-04411-y  PMID: 35042229 
  2. Hansen CH, Schelde AB, Moustsen-Helm IR, Emborg H-D, Krause TG, Mølbak K, et al. Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study. medRxiv. 2021.12.20.21267966. Preprint.  https://doi.org/10.1101/2021.12.20.21267966 
  3. World Health Organization (WHO). Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. Geneva: WHO; 26 Nov 2021. Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern#:~:text=Based%20on%20the%20evidence%20presented,as%20a%20VOC%2C%20named%20Omicron
  4. Zeng C, Evans JP, Qu P, Faraone J, Zheng Y-M, Carlin C, et al. Neutralization and stability of SARS-CoV-2 Omicron variant. bioRxiv. 2021.12.16.472934. Preprint.  https://doi.org/10.1101/2021.12.16.472934 
  5. Andrew R. Proposal to split B.1.1.529 to incorporate a newly characterised sibling lineage #361. Github. 7 Dec 2021. Available from: https://github.com/cov-lineages/pango-designation/issues/361
  6. United Kingdom Health Security Agency (UKHSA). SARS-CoV-2 variants of concern and variants under investigation in England – Technical Briefing 35. London: UKHSA; 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1050999/Technical-Briefing-35-28January2022.pdf
  7. World Health Organization (WHO). Enhancing response to Omicron SARS-CoV-2 variant: Technical brief and priority actions for Member States, Update #5. Geneva: WHO; 7 Jan 2022. Available from: https://www.who.int/docs/default-source/coronaviruse/2022-01-07-global-technical-brief-and-priority-action-on-omicron---corr2.pdf?sfvrsn=918b09d_20
  8. Statens Serum Institut (SSI). Now, an Omicron variant, BA.2, accounts for almost half of all Danish Omicron-cases. Copenhagen: SSI; 20 Jan 2022. Available from: https://en.ssi.dk/news/news/2022/omicron-variant-ba2-accounts-for-almost-half-of-all-danish-omicron-cases
  9. Espenhain L, Funk T, Overvad M, Edslev SM, Fonager J, Ingham AC, et al. Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021. Euro Surveill. 2021;26(50):2101146.  https://doi.org/10.2807/1560-7917.ES.2021.26.50.2101146  PMID: 34915977 
  10. Lyngse FP, Kirkeby CT, Denwood M, Christiansen LE, Mølbak K, Møller CH, et al. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish households. medRxiv. 2022.01.28.22270044. Preprint. https://doi.org/10.1101/2022.01.28.22270044
  11. Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob Chall. 2017;1(1):33-46.  https://doi.org/10.1002/gch2.1018  PMID: 31565258 
  12. Bager P, Wohlfahrt J, Bhatt S, Edslev SM, Sieber RN, Ingham AC, et al. Reduced risk of hospitalisation associated with infection with SARS-CoV-2 Omicron relative to Delta: A Danish cohort study. SSRN. 2021.4008930. Preprint. https://dx.doi.org/10.2139/ssrn.4008930
  13. Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 2002;30(14):3059-66.  https://doi.org/10.1093/nar/gkf436  PMID: 12136088 
  14. Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32(1):268-74.  https://doi.org/10.1093/molbev/msu300  PMID: 25371430 
  15. To TH, Jung M, Lycett S, Gascuel O. Fast dating using least-squares criteria and algorithms. Syst Biol. 2016;65(1):82-97.  https://doi.org/10.1093/sysbio/syv068  PMID: 26424727 
  16. Ishikawa SA, Zhukova A, Iwasaki W, Gascuel O. A fast likelihood method to reconstruct and visualize ancestral scenarios. Mol Biol Evol. 2019;36(9):2069-85.  https://doi.org/10.1093/molbev/msz131  PMID: 31127303 
  17. Wickham H. ggplot2: Elegant graphics for data analysis. Second edition. New York: Springer; 2016.
  18. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2021. Available from: https://www.r-project.org
  19. Aksamentov I, Roemer C, Hodcroft E, Neher R. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J Open Source Softw. 2021;6(67):3773.  https://doi.org/10.21105/joss.03773 
  20. Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296-303.  https://doi.org/10.1093/nar/gky427  PMID: 29788355 
  21. Zhang J, Cai Y, Xiao T, Lu J, Peng H, Sterling SM, et al. Structural impact on SARS-CoV-2 spike protein by D614G substitution. Science. 2021;372(6541):525-30.  https://doi.org/10.1126/science.abf2303  PMID: 33727252 
  22. Mannar D, Saville JW, Zhu X, Srivastava SS, Berezuk AM, Tuttle KS, et al. SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex. Science. 2022;375(6582):760-4.  https://doi.org/10.1126/science.abn7760  PMID: 35050643 
  23. Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2021;30(1):70-82.  https://doi.org/10.1002/pro.3943  PMID: 32881101 
  24. Veneti L, Bøås H, Bråthen Kristoffersen A, Stålcrantz J, Bragstad K, Hungnes O, et al. Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022. Euro Surveill. 2022;27(4)2200077.  https://doi.org/10.2807/1560-7917.ES.2022.27.4.2200077  PMID: 35086614 
  25. Brandal LT, MacDonald E, Veneti L, Ravlo T, Lange H, Naseer U, et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Euro Surveill. 2021;26(50)2101147.  https://doi.org/10.2807/1560-7917.ES.2021.26.50.2101147  PMID: 34915975 
  26. Lyngse FP, Mortensen LH, Denwood MJ, Christiansen LE, Møller CH, Skov RL, et al. SARS-CoV-2 Omicron VOC transmission in Danish households. medRxiv. 2021.12.27.21268278. Preprint. http://dx.doi.org/10.1101/2021.12.27.21268278
  27. Eggink D, Andeweg SP, Vennema H, van Maarseveen N, Vermaas K, Vlaemynck B, et al. Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022. Euro Surveill. 2022;27(4)210196.  https://doi.org/10.2807/1560-7917.ES.2022.27.4.2101196  PMID: 35086609 
  28. Watanabe Y, Berndsen ZT, Raghwani J, Seabright GE, Allen JD, Pybus OG, et al. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nat Commun. 2020;11(1):2688.  https://doi.org/10.1038/s41467-020-16567-0  PMID: 32461612 
  29. Tian W, Li D, Zhang N, Bai G, Yuan K, Xiao H, et al. O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an "O-Follow-N" rule. Cell Res. 2021;31(10):1123-5.  https://doi.org/10.1038/s41422-021-00545-2  PMID: 34341488 
  30. McCallum M, De Marco A, Lempp FA, Tortorici MA, Pinto D, Walls AC, et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021;184(9):2332-2347.e16.  https://doi.org/10.1016/j.cell.2021.03.028  PMID: 33761326 

Data & Media loading...

Supplementary data

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error